AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARDELYX, INC. Director's Dealing 2024

Aug 23, 2024

32003_dirs_2024-08-22_2d09cd61-c445-492b-bdc7-b0a0f084c311.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2024-08-20

Reporting Person: Williams Laura A (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-20	Common Stock	S	7412	$5.8603	Disposed	314740	Direct

Footnotes

F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.